ERBB2 and breast cancer: "The development of targeted biologics has been a major milestone in the treatment of HER2-positive metastatic breast cancer and has markedly improved survival," said Karen Herold, DNP, WHCNP-BC, FNP-BC, of Hoag Memorial Hospital Presbyterian, Newport Beach, California.